Ensign Peak Advisors’s Tango Therapeutics TNGX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-57,319
| Closed | -$177K | – | 1727 |
|
|
2024
Q4 | $177K | Buy |
57,319
+28,700
| +100% | +$88.7K | ﹤0.01% | 1698 |
|
|
2024
Q3 | $220K | Sell |
28,619
-243,203
| -89% | -$1.87M | ﹤0.01% | 1692 |
|
|
2024
Q2 | $2.33M | Sell |
271,822
-234,560
| -46% | -$2.01M | ﹤0.01% | 849 |
|
|
2024
Q1 | $4.02M | Buy |
506,382
+11,169
| +2% | +$88.7K | 0.01% | 692 |
|
|
2023
Q4 | $4.9M | Hold |
495,213
| – | – | 0.01% | 624 |
|
|
2023
Q3 | $5.58M | Hold |
495,213
| – | – | 0.01% | 538 |
|
|
2023
Q2 | $1.64M | Hold |
495,213
| – | – | ﹤0.01% | 952 |
|
|
2023
Q1 | $1.96M | Hold |
495,213
| – | – | ﹤0.01% | 864 |
|
|
2022
Q4 | $3.59M | Buy |
495,213
+107,260
| +28% | +$778K | 0.01% | 646 |
|
|
2022
Q3 | $1.4M | Buy |
387,953
+88,562
| +30% | +$321K | ﹤0.01% | 919 |
|
|
2022
Q2 | $1.36M | Buy |
299,391
+193,735
| +183% | +$877K | ﹤0.01% | 969 |
|
|
2022
Q1 | $801K | Hold |
105,656
| – | – | ﹤0.01% | 1324 |
|
|
2021
Q4 | $1.16M | Buy |
105,656
+52,156
| +97% | +$571K | ﹤0.01% | 1201 |
|
|
2021
Q3 | $692K | Buy |
+53,500
| New | +$692K | ﹤0.01% | 1549 |
|